Chia-Ying Lin

Chia-Ying Lin

Auto-generated profile, based on publicly available information

Chia-Ying Lin

Da Dian Biotechnology Company Limited, Pingtung, Taiwan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2016 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
Jayakumar ThanasekaranJayakumar Thanasekaran
Jayakumar Thanasekaran
KLKao-Chang Lin
Kao-Chang Lin
WLWan-Jung Lu
Wan-Jung Lu
CLChia-Ying Lin
Chia-Ying Lin
GPGeraldine Pitchairaj
Geraldine Pitchairaj
Joen-Rong SheuJoen-Rong Sheu
Joen-Rong Sheu
Nobiletin, a bioactive polymethoxylated flavone, has been described to possess a diversity of biological effects through its antioxidant and anti-inflammatory properties. Vasodilator-stimulated phosphoprotein (VASP) is a common substrate for cyclic AMP and cyclic GMP-regulated protein kinases [i.e., cyclic AMP-dependent protein kinase (PKA; also known as protein kinase A) and cyclic GMP-dependent protein kinase (PKG; also known as protein kinase G)] and it has been shown to be directly phosphorylated by protein kinase C (PKC). In the present study, we demonstrate that VASP is phosphorylated by nobiletin in human platelets via a non-cyclic nucleotide-related mechanism. This was confirmed by the use of inhibitors of adenylate cyclase (SQ22536) and guanylate cyclase [1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ)], since they prevented VASP phosphorylation induced by nobiletin. Furthormore, this event was also not affected by specific inhibitors of PKA (H-89), PKG (KT5823) and PKC (Ro318220), representing cyclic nucleotide-dependent pathways upon nobiletin-induced VASP phosphorylation. Similarly, inhibitors of p38 mitogen-activated protein kinase (MAPK; SB203580), extracellular signal-regulated kinase 2 (ERK2; PD98059), c-Jun N-terminal kinase 1 (JNK1; SP600125), Akt (LY294002) and nuclear factor-κB (NF-κB; Bay11-7082) did not affect nobiletin‑induced VASP phosphorylation. Moreover, electron spin resonance, dichlorofluorescein fluorescence and western blotting techniques revealed that nobiletin did not affect hydroxyl radicals (OH•), intracellular reactive oxygen species (ROS) and on protein carbonylation, respectively. Furthermore, the nobiletin‑induced VASP phosphorylation was surprisingly reversed by the intracellular antioxidant, N-acetylcysteine (NAC), but not by the inhibitor of NADPH oxidase, diphenyleneiodonium chloride (DPI). It was surprising to observe the differential effects of nobiletin and NAC on VASP phosphorylation in human platelets, since they both have been reported to have antioxidant properties. The likely explanation for this discrepancy is that NAC may bind to allosteric sites on the receptor different from those that nobiletin binds to in human platelets. Taken together, our findings suggest that nobiletin induces VASP phosphorylation in human platelets through non-cyclic nucleotide-related mechanisms. Nevertheless, the exact mechanisms responsible for these effects need to be further confirmed in future studies.

1 January 2021 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
CTChiu-Huang Ting
Chiu-Huang Ting
CLChia-Ying Lin
Chia-Ying Lin
YHYang-Chieh Huang
Yang-Chieh Huang
SLShyh-Shyan Liu
Shyh-Shyan Liu
SPShaoyu Peng
Shaoyu Peng
HWHung-Yi Wu
Hung-Yi Wu
Ting CH, et al. J Vet Sci. 2020 Dec;22:e1. https://doi.org/10.4142/jvs.2021.22.e1